INS and diabetes mellitus: Over the past several decades, there have been major advances in diabetes technology and management strategies as well as insulin delivery and formulations.1,2,3 However, little is known regarding recent patterns of glycemic control (glycated hemoglobin [HbA1c] level <7%; to convert percentage of total hemoglobin to proportion of total hemoglobin, multiply by 0.01; to convert to millimoles per mole, multiply by 10.93 and subtract by 23.50) among patients using insulin.